Literature DB >> 1334156

The Fifth Edition of the Addiction Severity Index.

A T McLellan1, H Kushner, D Metzger, R Peters, I Smith, G Grissom, H Pettinati, M Argeriou.   

Abstract

The Addiction Severity Index (ASI) is 12 years old and has been revised to include a new section on family history of alcohol, drug, and psychiatric problems. New items were added in existing sections to assess route of drug administration; additional illegal activities; emotional, physical, and sexual abuse; quality of the recovery environment; and history of close personal relationships. No changes were made in the composite scoring to maintain comparability with previous editions. This article discusses the clinical and research uses of the ASI over the past 12 years, emphasizing some special circumstances that affect its administration. The article then describes the rationale for and description of the changes made in the ASI. The final section provides "normative data" on the composite scores and severity ratings for samples of opiate, alcohol, and cocaine abusers as well as drug abusing inmates, pregnant women, homeless men, and psychiatrically ill substance abusers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334156     DOI: 10.1016/0740-5472(92)90062-s

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  1485 in total

1.  Psychosocial versus nicotine-only self-report measures for predicting follow-up smoking status.

Authors:  W J McCarthy; Y Zhou; Y I Hser
Journal:  J Behav Med       Date:  2001-02

2.  Motivational versus confrontational interviewing: a comparison of substance abuse assessment practices at employee assistance programs.

Authors:  R J Schneider; J Casey; R Kohn
Journal:  J Behav Health Serv Res       Date:  2000-02       Impact factor: 1.505

3.  Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention.

Authors:  M O Rigsby; M I Rosen; J E Beauvais; J A Cramer; P M Rainey; S S O'Malley; K D Dieckhaus; B J Rounsaville
Journal:  J Gen Intern Med       Date:  2000-12       Impact factor: 5.128

4.  Medicaid patients in a private health maintenance organization: patterns of chemical dependency treatment.

Authors:  Lawrence J Walter; Sujaya Parthasarathy; Steven Allen; Lynn Ackerson
Journal:  J Behav Health Serv Res       Date:  2002-02       Impact factor: 1.505

5.  Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.

Authors:  K M Carroll; S A Ball; C Nich; P G O'Connor; D A Eagan; T L Frankforter; E G Triffleman; J Shi; B J Rounsaville
Journal:  Arch Gen Psychiatry       Date:  2001-08

6.  Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI.

Authors:  Michael T French; Helena J Salomé; Jody L Sindelar; A Thomas McLellan
Journal:  Health Serv Res       Date:  2002-04       Impact factor: 3.402

7.  A prospective study of the factors influencing entry to alcohol and drug treatment.

Authors:  Constance Weisner; Helen Matzger
Journal:  J Behav Health Serv Res       Date:  2002-05       Impact factor: 1.505

8.  Impact of Intensive Case Management on Child Welfare System Involvement for Substance-Dependent Parenting Women on Public Assistance.

Authors:  Sarah Dauber; Charles Neighbors; Chris Dasaro; Annette Riordan; Jon Morgenstern
Journal:  Child Youth Serv Rev       Date:  2012-03-30

9.  Symptoms of anhedonia, not depression, predict the outcome of treatment of cocaine dependence.

Authors:  Paul Crits-Christoph; Steven Wadden; Averi Gaines; Agnes Rieger; Robert Gallop; James R McKay; Mary Beth Connolly Gibbons
Journal:  J Subst Abuse Treat       Date:  2018-06-21

10.  Socioemotional effects of fathers' incarceration on low-income, urban, school-aged children.

Authors:  MaryAnn B Wilbur; Jodi E Marani; Danielle Appugliese; Ryan Woods; Jane A Siegel; Howard J Cabral; Deborah A Frank
Journal:  Pediatrics       Date:  2007-09       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.